Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Einfluss saisonaler Faktoren auf das Kopfhautmikrobiom und die Hautbarriereintegrität bei seborrhoischer Dermatitis
Projektleitung: Joshi Aaroh Anand
Laufzeit: 01.12.2025 - 31.07.2027
Geldgeber: Vichy Laboratoires International | L’Oréal

Rätselhafte Aktivierung der präsynaptischen Glykolyse
Projektleitung: Koshenov Zhanat
Laufzeit: 01.01.2026 - 31.12.2027
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

22.09.2025:

Roney, C; Plank, G; Honarbakhsh, S; Vidal, Horrach, C; Pezzuto, S; Vigmond, E Recovering intrinsic conduction velocity and action potential duration from electroanatomic mapping data using curvature.
Med Image Anal. 2025; 107(Pt A):103809 Doi: 10.1016/j.media.2025.103809
PubMed FullText FullText_MUG

 

22.09.2025:

Kieninger, B; Wagner, GE; Rath, A; Eichner, A; Fritsch, J; Caplunik-Pratsch, A; Alikhani, J; Heydarzadeh-Ghamsary, P; Cabal-Rosel, A; Ruppitsch, W; Harmsen, D; Abdulla, MR; Ulm, L; Becker, K; Schneider-Brachert, W; Kohler, C Development and validation of a core genome multilocus sequence typing scheme for Citrobacter freundii: application in outbreak investigations and comparative analysis across the Citrobacter genus.
J Clin Microbiol. 2025; e0086025 Doi: 10.1128/jcm.00860-25
PubMed FullText FullText_MUG

 

22.09.2025:

Kühn, T; Banys-Paluchowski, M; Ditsch, N; Stickeler, E; Hauptmann, M; Schroth, J; Karadeniz, Cakmak, G; Hahn, M; Thill, M; Reimer, T; Fröhlich, S; Schmidt, E; Wihlfahrt, K; Berger, T; Basali, T; Ruf, F; Rief, A; Lux, MP; Kolberg, HC; Rubio, IT; Gasparri, ML; Kontos, M; Bonci, EA; Niinikoski, L; Murawa, D; Pinto, D; Peintinger, F; Schlichting, E; Nina, H; Valiyeva, Qanimat, H; Vanhoeij, M; Rebaza, LP; Aktas, Sezen, B; Jursik, K; Kadayaprath, G; Dostalek, L; Kothari, A; Perhavec, A; Ivanov, T; Zippel, D; Thongvitokomarn, S; Gurleyik, MG; Watermann, D; Porpiglia, M; Lebeau, A; Di, Micco, R; Gentilini, OD; de, Boniface, J; Hartmann, S, , AXSANA, Study, Group Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study.
Br J Surg. 2025; 112(9): Doi: 10.1093/bjs/znaf180
PubMed FullText FullText_MUG

 

22.09.2025:

Hatzl, S; Kriegl, L; Geiger, C; Wilhelmer, C; Reisinger, AC; Keldorfer, M; Auinger, J; Schilcher, G; Krammer, F; Eller, P; Krause, R Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study.
Clin Infect Dis. 2025; Doi: 10.1093/cid/ciaf507
PubMed FullText FullText_MUG

 

22.09.2025:

Mathieu, C; Wych, J; Hendriks, AEJ; Van, Ryckeghem, L; Tree, T; Chmura, P; Möller, C; Casteels, K; Danne, T; Reschke, F; Šmigoc, Schweiger, D; Battelino, T; Johannesen, J; Rami-Merhar, B; Pieber, T; De, Block, C; Evans, M; Hilbrands, R; Bosi, E; Willemsen, RH; Basu, S; Pulkkinen, MA; Knip, M; Cnop, M; Nitsche, A; Schulte, AM; Niemöller, E; Peakman, M; Wilhelm-Benartzi, C; Gillespie, D; Overbergh, L; Mander, AP; Marcovecchio, ML, , INNODIA Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.
Lancet. 2025; Doi: 10.1016/S0140-6736(25)01674-5
PubMed FullText FullText_MUG

 

22.09.2025:

Rodrigues, MA; Seiffge, D; Samarasekera, N; Moullaali, TJ; Wardlaw, JM; Schreiber, S; Behymer, TP; Khandwala, V; Stanton, RJ; Vagal, V; Woo, D; Zedde, M; Pascarella, R; Charidimou, A; Warren, A; Greenberg, SM; Eppinger, S; Gattringer, T; Casolla, B; Cordonnier, C; Werring, DJ; Al-Shahi, Salman, R, , Edinburgh, CAA, criteria, prognosis, collaborators Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis.
Lancet Neurol. 2025; 24(10):828-839 Doi: 10.1016/S1474-4422(25)00285-6
PubMed FullText FullText_MUG

 

22.09.2025:

Kohlhauser, M; Vasilyeva, A; Bürger, H; Anderhuber, F; Kamolz, LP; Schintler, M An analysis of the medial femoral condyle flap anatomy and the involvement of different tissue components for the reconstruction of complex defects.
Bone Joint Res. 2025; 14(9):795-804 Doi: 10.1302/2046-3758.149.BJR-2024-0536.R2 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

22.09.2025:

Zhang, L; Gottschalk, B; Dietsche, F; Bitar, S; Bueno, D; Rojas-Charry, L; Kumari, A; Garg, V; Graier, WF; Methner, A Interaction of the mitochondrial calcium/proton exchanger TMBIM5 with MICU1.
Commun Biol. 2025; 8(1):1348 Doi: 10.1038/s42003-025-08839-6 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

22.09.2025:

Rivière, JG; Bastarache, L; Campos, LC; Carot-Sans, G; Chin, A; Chunara, R; Cunningham-Rundles, C; Erra, L; Farmer, J; Garcelon, N; Hsieh, E; Leavis, H; Lee, S; Liu, L; Kusters, M; Lloyd, BC; Martinson, AK; Mester, R; Moore, JB; Moshous, D; Orange, JS; Parrish, N; Parker, SH; Pasaniuc, B; Peng, XP; Pergent, M; Piera-Jiménez, J; Quinn, J; Ramesh, S; Roberts, K; Robinson, P; Savova, G; Scalchunes, C; Seidel, MG; Simoneau, R; Soler-Palacin, P; Sullivan, K; Van, Gijn, M; Wi, CI; Zhou, D; Tenembaum, V; Butte, M; Rider, NL Proceedings of the Second Artificial Intelligence in Primary Immunodeficiencies (AIPI) Meeting.
J Allergy Clin Immunol. 2025; Doi: 10.1016/j.jaci.2025.09.002
PubMed FullText FullText_MUG

 

21.09.2025:

Barkhof, F; Reich, DS; Oh, J; Rocca, MA; Li, DKB; Sati, P; Azevedo, CJ; Bagnato, F; Calabresi, PA; Ciccarelli, O; Dwyer, MG; DeLuca, GC; De, Stefano, N; Enzinger, C; Filippi, M; Granziera, C; Halper, J; Henry, RG; Gasperini, C; Gauthier, S; Kappos, L; Laule, C; Newsome, SD; Montalban, X; Morrow, SA; Schoonheim, MM; Sicotte, N; Toosy, A; Wilken, J; Yousry, T; Sastre-Garriga, J; Traboulsee, A; Ontaneda, D; Rovira, À, , Magnetic, Resonance, Imaging, Network, in, Multiple, Sclerosis;Consortium, of, Multiple, Sclerosis, Centers;North, American, Imaging, in, Multiple, Sclerosis, Cooperative, MRI, guidelines, working, group 2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis.
Lancet Neurol. 2025; 24(10):866-879 Doi: 10.1016/S1474-4422(25)00304-7
PubMed FullText FullText_MUG

 

18.09.2025:

Artinger, K; Novitzky-Basso, I; Klötzer, KA; Anto-Michel, N; Schabhuettl, C; Gutjahr, JC; Samus, M; Hub, E; Kirsch, AH; Leitinger, D; Wernitznig, S; Umeizudike, T; Pollheimer, M; Ulvmar, MH; Mooslechner, AA; Bacon, A; Eller, P; Kroneis, T; Kratky, D; Rosenkranz, AR; Eller, K; Rot, A Erythroid ACKR1 Deficiency Aggravates Immune-Mediated Kidney Disease.
J Am Soc Nephrol. 2025; Doi: 10.1681/ASN.0000000878
PubMed FullText FullText_MUG

 

17.09.2025:

Hadzic, A; Bogensperger, L; Berghold, A; Urschler, M Flow Matching-Based Data Synthesis for Robust Anatomical Landmark Localization.
IEEE J Biomed Health Inform. 2025; PP: Doi: 10.1109/JBHI.2025.3603907
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.